Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC6 Gene Transfer for Congestive Heart Failure
NCT00787059Phase 2Completed
- Start
- Jul 2010
- Primary completion
- Jan 2015
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Ad5.hAC6 with Placebo (2 arms). Primary endpoints: Exercise treadmill time at 12 weeks, Left ventricular function by echocardiography at 12 weeks and 1 more. Started Jul 2010; status: completed.
02
Drugs
RT-100
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00787059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00787059.